about
Leptin- or troglitazone-induced lipopenia protects islets from interleukin 1beta cytotoxicityIncreased oxidative stress in obesity and its impact on metabolic syndromeRationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial.Gender-linked impact of epicardial adipose tissue volume in patients who underwent coronary artery bypass graft surgery or non-coronary valve surgeryMicroRNA-378 regulates adiponectin expression in adipose tissue: a new plausible mechanism.Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus.Effect of combination tablets containing amlodipine 10 mg and irbesartan 100 mg on blood pressure and cardiovascular risk factors in patients with hypertension.Serum concentration of eicosapentaenoic acid is associated with cognitive function in patients with coronary artery diseaseA novel insulinotropic mechanism of whole grain-derived γ-oryzanol via the suppression of local dopamine D2 receptor signalling in mouse isletReduced ratio of eicosapentaenoic acid and docosahexaenoic acid to arachidonic acid is associated with early onset of acute coronary syndromeGender disparities in the association between epicardial adipose tissue volume and coronary atherosclerosis: a 3-dimensional cardiac computed tomography imaging study in Japanese subjectsBrown rice and its component, γ-oryzanol, attenuate the preference for high-fat diet by decreasing hypothalamic endoplasmic reticulum stress in mice.Eicosapentaenoic Acid supplementation changes Fatty Acid composition and corrects endothelial dysfunction in hyperlipidemic patients.Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistanceImpact of individual metabolic risk components or its clustering on endothelial and smooth muscle cell function in men.Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study.Association of lower limb muscle mass and energy expenditure with visceral fat mass in healthy men.Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice.γ-Oryzanol protects pancreatic β-cells against endoplasmic reticulum stress in male mice.HMGB1 plays a critical role in vascular inflammation and lesion formation via toll-like receptor 9.Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice.Glycemic Control with Ipragliflozin, a Novel Selective SGLT2 Inhibitor, Ameliorated Endothelial Dysfunction in Streptozotocin-Induced Diabetic MouseSubclinical Carotid Atherosclerosis Burden in the Japanese: Comparison between Okinawa and Nagano Residents.Plasma microRNA-100 is associated with coronary plaque vulnerability.Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser(1177)/Thr(497) of endothelial nitric oxide synthase in diabetic mice.The radioprotective 105/MD-1 complex contributes to diet-induced obesity and adipose tissue inflammation.Induction of uncoupling protein-2 mRNA by troglitazone in the pancreatic islets of Zucker diabetic fatty rats.Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice.Activation of AMPK-Sirt1 pathway by telmisartan in white adipose tissue: A possible link to anti-metabolic effects.Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis.Pentraxin 3 is a local inflammatory marker in atrial fibrillation.Cilazapril prevents cardiac hypertrophy and postischemic myocardial dysfunction in hyperthyroid rats.Effect of ghrelin on autonomic activity in healthy volunteers.Identification of three new mutations of the HNF-1 alpha gene in Japanese MODY families.Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury.Defects of vascular nitric oxide bioavailability in subjects with impaired glucose tolerance: a potential link to insulin resistance.Brachial-ankle pulse wave velocity predicts all-cause mortality and cardiovascular events in patients with diabetes: the Kyushu Prevention Study of Atherosclerosis.Perivascular adipose tissue-secreted angiopoietin-like protein 2 (Angptl2) accelerates neointimal hyperplasia after endovascular injury.Electrophysiologic characteristics of atrial myocytes in levo-thyroxine-treated rats.Miglitol, α-glycosidase inhibitor, reduces visceral fat accumulation and cardiovascular risk factors in subjects with the metabolic syndrome: a randomized comparable study.
P50
Q28379134-0B1B6B68-DA28-4F8A-AFA9-4BC64B46E35CQ29012150-DA2F68DF-DB8D-44C4-A9C9-2061DF5936EEQ33556240-52049A26-D889-4581-8526-CE79C8FB77BBQ33778220-5479A7DF-483E-446A-A6F9-0CB4FDB515FDQ34472910-D7DC166F-0502-4248-89CC-D29DC5F1D79AQ34672517-A3F4493D-E4DB-40A1-B992-F7A3FA2C94EBQ34977468-944D211D-9E3F-4F48-BFD7-BE44C21666DEQ35341268-88466EF6-ACC3-49D4-BA16-EB168487B854Q36036244-E158750F-0085-4F9F-AA98-A39A3FA08E56Q36232346-A06A3CBB-311F-4007-8560-274BE8AC3D54Q36373276-9EB6DE11-D8AE-40EE-821D-7074B2720AFBQ36410722-5DD8F0D2-0E8C-422E-89FA-D42ABD3208D1Q36522472-A442AEB3-87A5-47C6-8A84-B929BF4DC3E8Q36764022-1AF04C8E-E787-4C55-BF79-50391F0EDAC5Q36906999-37484EFA-4EA9-4CB0-99F6-8EF8A2230C2AQ37251449-5E1E4B6F-FDA9-4A4E-B021-0EBCFF6244F6Q37623338-75628B0B-3B13-479D-BAC0-5EE2887B58F7Q38894035-5101CC16-54EB-40ED-A0E4-8EA41CD28503Q38919324-14C385C3-5213-4A00-B2CC-C6A131EB2E4EQ39057962-0C7AD5D1-4F6F-4190-B654-D8571799E623Q39247798-260F62F7-8E81-4F08-B9A5-EBA85B37D0CFQ41579741-3B90E520-8EFB-4702-829C-053DB3EE9F0EQ41622358-61034795-D1B1-47D2-9166-1DAC342E0C1FQ41677324-7CD0F6F9-7C32-437D-88A9-EFABD35BB39AQ41922933-CDE13BA7-30F0-40A7-8AA3-567EA19ABD97Q41966425-7E60B731-263C-439D-878C-8745CE6BE2FBQ42548042-10C497F3-1C7E-4D67-8823-DCE1F136B09FQ42801660-C6356585-9FFD-4E03-A872-A166BC295B02Q42832526-60271C52-346C-4FA7-867F-891B63CA29E0Q43442853-33A3D0F1-6224-4B3C-98E3-6111783249C1Q43824291-1C66BDDB-C2E3-42D4-9E0B-259D902D61D7Q43837148-606A471B-4B4C-4471-A49F-F0E3D4A1DCBEQ44232590-D8CF388E-0DC1-43C8-A139-15E87A75097FQ44253821-98007BB6-A684-454B-A07C-F8FF379D9B32Q44321259-0B03936D-691B-4CCC-B759-2347A1B9F18EQ44643688-15137A7D-AD67-48F4-B72D-2E203F060F98Q44663625-AC30512F-30C5-4D0E-9886-60D10DE19747Q44983160-AF97E621-5C2E-40C7-A3E8-F96117C1FAE3Q45248834-6A5B22AF-B953-4294-A571-98B63B1EF2F6Q46527687-2C29165A-71F4-4861-824F-55B15A9DE21E
P50
description
Japanese internist and medical reseacher
@en
academisch docent
@nl
日本の医学者、内科医師
@ja
name
Michio Shimabukuro
@ast
Michio Shimabukuro
@en
Michio Shimabukuro
@es
Michio Shimabukuro
@nl
Michio Shimabukuro
@sl
島袋充生
@ja
type
label
Michio Shimabukuro
@ast
Michio Shimabukuro
@en
Michio Shimabukuro
@es
Michio Shimabukuro
@nl
Michio Shimabukuro
@sl
島袋充生
@ja
prefLabel
Michio Shimabukuro
@ast
Michio Shimabukuro
@en
Michio Shimabukuro
@es
Michio Shimabukuro
@nl
Michio Shimabukuro
@sl
島袋充生
@ja
P31
P496
0000-0001-7835-7665